"Welcome to SSJ Finance"

Profit & Loss Accounts

Quarterly Results

Emcure Pharmaceuticals Ltd
Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln	Chairman : Berjis M Desai
Home : Indian Private	Book Value: 169.5124332
BSE Code : 544210	Market Cap: 26451.88
NSE Code : EMCURE	P / E : 61.12

Change Company :

Quarters:

(Rs in Cr.)

Quarterly Results

Particulars	Sep 2025	Jun 2025	Mar 2025	Dec 2024
Type	2Qtr	1Qtr	4Qtr	3Qtr
Net Sales	1260.60	1096.57	1278.19	1028.81
Other Income	22.75	21.52	22.40	26.52
Total Income	1283.36	1118.10	1300.58	1055.34
Total Expenditure	1036.01	872.07	1033.55	911.51
Operating Profit	247.34	246.02	267.03	143.83
Interest	27.71	20.54	24.07	19.93
Gross Profit	219.63	225.49	242.96	123.90
Depreciation	61.74	59.82	56.91	56.65
Tax	45.98	44.00	63.59	6.53
Deferred Tax	-5.71	-1.12	-17.10	10.52
Reported Profit After Tax	117.62	122.79	139.56	50.20

SSJ FINANCE & SECURITIES PRIVATE LIMITED:
1st Floor, Merchant Chamber, Opp. Patkar Hall, 41, New Marine Lines, Mumbai – 400 020
SEBI Regn. Number: INZ000178436 | CDSL: IN-DP-109-2015 | ARN: 40860 | CIN: U67120MH1996PTC104822

SSJ COMMODITIES PRIVATE LIMITED:
SEBI Regn. Number: INZ000013439 | CIN: U51909MH2003PTC140481|Research Analyst SEBI Reg. No.INH000001527

Content powered by Capital Market Charts are powered by TradingView